Cancer Treatment - Costa Rica Newlook About Us - Our Services - Why Costa Rica - Contact Us - Testimonials
Cancer Treatment - Costa Rica Newlook
Cancer Treatment

Skin Cancer Costa Rica

The team of health professionals that specializes in Skin Cancer includes: skin specialists (dermatologists), plastic surgeons, and cancer specialists.

About Melanoma Skin Cancer

Skin cancer is the most common cancer in the United States, and it is increasing at an alarming rate. Although highly treatable forms of the disease, such as basal cell and squamous cell carcinomas, are on the rise, the greatest increase has been in melanoma, the most deadly skin cancer. There are four main types of melanoma, and each has unique symptoms. The disease typically arises painlessly from cells that produce the skin's pigment (melanin). Approximately 70 percent of these cancers appear on normal skin; 30 percent arise from an existing mole that has undergone sudden changes in color, size, pain, itching, bleeding or swelling. If left untreated the tumor can spread downward into other areas of the skin or to lymph nodes or internal organs.

Treatment options include surgery, radiation therapy, chemotherapy and others. Treatment decisions are made by a multidisciplinary team, including the patient, which considers the multitude of options for therapy and selects a treatment strategy based on the specifics of each case.

About Non-melanoma Skin Cancer

Skin cancer the abnormal growth of skin cells is by far the most common form of cancer diagnosed today. About 2 million skin cancer cases are diagnosed annually in the United States. Skin cancer has two major types, nonmelanoma and melanoma. Non-melanoma is more prevalent. Most skin tumors are not cancerous and can be treated in the doctor's office.

For most skin cancers, treatment options include curettage and electrodesiccation, cryosurgery (freezing), photodynamic therapy, laser therapy, traditional surgery and Mohs surgery. Dermatologists advise each patient about the most appropriate therapies based on the severity of the cancer.